Real-world management of oral mucositis/stomatitis among patients with advanced non-small cell lung cancer (NSCLC) or breast cancer (BC)
OM/S occurs across cancer treatment regimens and can lead to treatment modification. Improvements in OM/S management at the patient and provider level are needed to enhance care and improve clinical outcomes.
Authors
- Prathamesh Pathak (ORCID: https://orcid.org/0009-0003-6107-4185)
- Jon Apple (ORCID: https://orcid.org/0000-0003-0941-4392)
- Sarah Lucht (ORCID: https://orcid.org/0000-0001-5904-2844)
- Marvin Nguyen
- Ruchit Shah (ORCID: https://orcid.org/0000-0002-3553-6142)
- Caleb Paydar (ORCID: https://orcid.org/0000-0003-1636-5947)
- William S. John
- Monica Ahlquist
- JaLyna Laney
- Bryce A. Allen-Van Doren
- Bruce Feinberg
Institutions
- Daiichi Sankyo (Germany) (DE)
- AstraZeneca (Brazil) (BR)
- Daiichi-Sankyo (South Korea) (KR)
- Cardinal Health (United States) (US)
Publication Details
- Journal
- Future Oncology
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1080/14796694.2025.2609979
- Primary Topic
- Oral health in cancer treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00